DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



High Dose Nimodipine Treatment Adjunct - 1

Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders

Intervention: Nimodipine (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Steven Deutsch, M.D., Principal Investigator, Affiliation: Washington DC VA

Summary

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Clinical Details

Official title: High Dose Nimodipine Pharmacotherapy Adjunct

Study design: Treatment

Primary outcome:

Stimulated and non-stimulated craving

Stimulated and non-stimulated withdrawal

Anxiety, depression

Heart rate

Eligibility

Minimum age: 22 Years. Maximum age: 45 Years. Gender(s): Both.

Criteria:

Please contact site for information.

Locations and Contacts

Washington DC VA, Washington, District of Columbia 20422, United States
Additional Information


Last updated: June 23, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012